<?xml version="1.0" encoding="UTF-8" ?>
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Cancer Cell Direct Bioprinting: A Focused Review</dc:title>
<dc:creator>Angelats Lobo, David</dc:creator>
<dc:creator>Ginestra, Paola</dc:creator>
<dc:creator>Ceretti, Elisabetta</dc:creator>
<dc:creator>Puig i Miquel, Teresa</dc:creator>
<dc:creator>Ciurana, Quim de</dc:creator>
<dc:subject>Three-dimensional printing</dc:subject>
<dc:subject>Impressió 3D</dc:subject>
<dc:subject>Materials biomèdics</dc:subject>
<dc:subject>Biomedical materials</dc:subject>
<dc:description>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</dc:description>
<dc:date>2021-06-28</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:type>peer-reviewed</dc:type>
<dc:identifier>http://hdl.handle.net/10256/19663</dc:identifier>
<dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/mi12070764</dc:relation>
<dc:relation>info:eu-repo/semantics/altIdentifier/eissn/2072-666X</dc:relation>
<dc:language>eng</dc:language>
<dc:source>Micromachines, 2021, vol. 12, núm. 7, p. 764</dc:source>
<dc:source>Articles publicats (D-CM)</dc:source>
<dc:rights>Attribution 4.0 International</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>MDPI (Multidisciplinary Digital Publishing Institute)</dc:publisher>
</oai_dc:dc>
<?xml version="1.0" encoding="UTF-8" ?>
<d:DIDL schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2021-06-29T06:08:56Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10256_19663">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10256/19663</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Cancer Cell Direct Bioprinting: A Focused Review</dc:title>
<dc:creator>Angelats Lobo, David</dc:creator>
<dc:creator>Ginestra, Paola</dc:creator>
<dc:creator>Ceretti, Elisabetta</dc:creator>
<dc:creator>Puig i Miquel, Teresa</dc:creator>
<dc:creator>Ciurana, Quim de</dc:creator>
<dc:subject>Three-dimensional printing</dc:subject>
<dc:subject>Impressió 3D</dc:subject>
<dc:subject>Materials biomèdics</dc:subject>
<dc:subject>Biomedical materials</dc:subject>
<dc:description>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</dc:description>
<dc:date>2021-06-29T06:08:56Z</dc:date>
<dc:date>2021-06-29T06:08:56Z</dc:date>
<dc:date>2021-06-28</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>http://hdl.handle.net/10256/19663</dc:identifier>
<dc:identifier>https://doi.org/10.3390/mi12070764</dc:identifier>
<dc:identifier>035460</dc:identifier>
<dc:identifier>2072-666X</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Reproducció digital del document publicat a: https://doi.org/10.3390/mi12070764</dc:relation>
<dc:relation>Micromachines, 2021, vol. 12, núm. 7, p. 764</dc:relation>
<dc:relation>Articles publicats (D-CM)</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Attribution 4.0 International</dc:rights>
<dc:publisher>MDPI (Multidisciplinary Digital Publishing Institute)</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10256_19663_1">
</d:Component>
</d:Item>
</d:DIDL>
<?xml version="1.0" encoding="UTF-8" ?>
<dim:dim schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field element="contributor" mdschema="dc" qualifier="author">Angelats Lobo, David</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Ginestra, Paola</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Ceretti, Elisabetta</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Puig i Miquel, Teresa</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Ciurana, Quim de</dim:field>
<dim:field element="date" mdschema="dc" qualifier="accessioned">2021-06-29T06:08:56Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="available">2021-06-29T06:08:56Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="issued">2021-06-28</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="uri">http://hdl.handle.net/10256/19663</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="doi">https://doi.org/10.3390/mi12070764</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="idgrec">035460</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="eissn">2072-666X</dim:field>
<dim:field element="description" mdschema="dc" qualifier="abstract">Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</dim:field>
<dim:field element="description" mdschema="dc" qualifier="provenance">Submitted by CLAUDIA PLANA (claudia.plana@udg.edu) on 2021-06-29T06:08:56Z No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) CancerCellDirect.pdf: 513353 bytes, checksum: 3613abadef03e623c2fc50320dafb8d8 (MD5)</dim:field>
<dim:field element="description" mdschema="dc" qualifier="provenance">Made available in DSpace on 2021-06-29T06:08:56Z (GMT). No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) CancerCellDirect.pdf: 513353 bytes, checksum: 3613abadef03e623c2fc50320dafb8d8 (MD5) Previous issue date: 2021-06-28</dim:field>
<dim:field element="format" mdschema="dc" qualifier="mimetype">application/pdf</dim:field>
<dim:field element="language" mdschema="dc" qualifier="iso">eng</dim:field>
<dim:field element="publisher" mdschema="dc">MDPI (Multidisciplinary Digital Publishing Institute)</dim:field>
<dim:field element="relation" mdschema="dc" qualifier="isformatof">Reproducció digital del document publicat a: https://doi.org/10.3390/mi12070764</dim:field>
<dim:field element="relation" mdschema="dc" qualifier="ispartof">Micromachines, 2021, vol. 12, núm. 7, p. 764</dim:field>
<dim:field element="relation" mdschema="dc" qualifier="ispartofseries">Articles publicats (D-CM)</dim:field>
<dim:field element="rights" mdschema="dc">Attribution 4.0 International</dim:field>
<dim:field element="rights" mdschema="dc" qualifier="uri">http://creativecommons.org/licenses/by/4.0/</dim:field>
<dim:field element="rights" mdschema="dc" qualifier="accessRights">info:eu-repo/semantics/openAccess</dim:field>
<dim:field element="subject" mdschema="dc">Three-dimensional printing</dim:field>
<dim:field element="subject" mdschema="dc">Impressió 3D</dim:field>
<dim:field element="subject" mdschema="dc">Materials biomèdics</dim:field>
<dim:field element="subject" mdschema="dc">Biomedical materials</dim:field>
<dim:field element="title" mdschema="dc">Cancer Cell Direct Bioprinting: A Focused Review</dim:field>
<dim:field element="type" mdschema="dc">info:eu-repo/semantics/article</dim:field>
<dim:field element="type" mdschema="dc" qualifier="version">info:eu-repo/semantics/publishedVersion</dim:field>
<dim:field element="type" mdschema="dc" qualifier="peerreviewed">peer-reviewed</dim:field>
</dim:dim>
<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">
<edm:ProvidedCHO about="https://catalonica.bnc.cat/catalonicahub/lod/oai:dugi-doc.udg.edu:10256_--_19663#ent0">
<dc:creator>Angelats Lobo, David</dc:creator>
<dc:creator>Ginestra, Paola</dc:creator>
<dc:creator>Ceretti, Elisabetta</dc:creator>
<dc:creator>Puig i Miquel, Teresa</dc:creator>
<dc:creator>Ciurana, Quim de</dc:creator>
<dc:date>2021-06-28</dc:date>
<dc:description>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</dc:description>
<dc:identifier>http://hdl.handle.net/10256/19663</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>MDPI (Multidisciplinary Digital Publishing Institute)</dc:publisher>
<dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/mi12070764</dc:relation>
<dc:relation>info:eu-repo/semantics/altIdentifier/eissn/2072-666X</dc:relation>
<dc:rights>Attribution 4.0 International</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:source>Micromachines, 2021, vol. 12, núm. 7, p. 764</dc:source>
<dc:source>Articles publicats (D-CM)</dc:source>
<dc:subject>Three-dimensional printing</dc:subject>
<dc:subject>Impressió 3D</dc:subject>
<dc:subject>Materials biomèdics</dc:subject>
<dc:subject>Biomedical materials</dc:subject>
<dc:title>Cancer Cell Direct Bioprinting: A Focused Review</dc:title>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:type>peer-reviewed</dc:type>
<edm:type>TEXT</edm:type>
</edm:ProvidedCHO>
<ore:Aggregation about="https://catalonica.bnc.cat/catalonicahub/lod/oai:dugi-doc.udg.edu:10256_--_19663#ent1">
<edm:dataProvider>DUGiDocs. Recerca</edm:dataProvider>
<edm:provider>Catalònica</edm:provider>
</ore:Aggregation>
</rdf:RDF>
<?xml version="1.0" encoding="UTF-8" ?>
<thesis schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>Cancer Cell Direct Bioprinting: A Focused Review</title>
<creator>Angelats Lobo, David</creator>
<creator>Ginestra, Paola</creator>
<creator>Ceretti, Elisabetta</creator>
<creator>Puig i Miquel, Teresa</creator>
<creator>Ciurana, Quim de</creator>
<subject>Three-dimensional printing</subject>
<subject>Impressió 3D</subject>
<subject>Materials biomèdics</subject>
<subject>Biomedical materials</subject>
<description>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</description>
<date>2021-06-29</date>
<date>2021-06-29</date>
<date>2021-06-28</date>
<type>info:eu-repo/semantics/article</type>
<identifier>http://hdl.handle.net/10256/19663</identifier>
<identifier>https://doi.org/10.3390/mi12070764</identifier>
<identifier>035460</identifier>
<identifier>2072-666X</identifier>
<language>eng</language>
<relation>Reproducció digital del document publicat a: https://doi.org/10.3390/mi12070764</relation>
<relation>Micromachines, 2021, vol. 12, núm. 7, p. 764</relation>
<relation>Articles publicats (D-CM)</relation>
<rights>http://creativecommons.org/licenses/by/4.0/</rights>
<rights>info:eu-repo/semantics/openAccess</rights>
<rights>Attribution 4.0 International</rights>
<publisher>MDPI (Multidisciplinary Digital Publishing Institute)</publisher>
</thesis>
<?xml version="1.0" encoding="UTF-8" ?>
<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield ind1=" " ind2=" " tag="042">
<subfield code="a">dc</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Angelats Lobo, David</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Ginestra, Paola</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Ceretti, Elisabetta</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Puig i Miquel, Teresa</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Ciurana, Quim de</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="260">
<subfield code="c">2021-06-28</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="520">
<subfield code="a">Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">http://hdl.handle.net/10256/19663</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">https://doi.org/10.3390/mi12070764</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">035460</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">2072-666X</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Three-dimensional printing</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Impressió 3D</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Materials biomèdics</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Biomedical materials</subfield>
</datafield>
<datafield ind1="0" ind2="0" tag="245">
<subfield code="a">Cancer Cell Direct Bioprinting: A Focused Review</subfield>
</datafield>
</record>
<?xml version="1.0" encoding="UTF-8" ?>
<mets ID=" DSpace_ITEM_10256-19663" OBJID=" hdl:10256/19663" PROFILE="DSpace METS SIP Profile 1.0" TYPE="DSpace ITEM" schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd">
<metsHdr CREATEDATE="2022-07-22T23:13:48Z">
<agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
<name>DUGiDocs</name>
</agent>
</metsHdr>
<dmdSec ID="DMD_10256_19663">
<mdWrap MDTYPE="MODS">
<xmlData schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Angelats Lobo, David</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Ginestra, Paola</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Ceretti, Elisabetta</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Puig i Miquel, Teresa</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Ciurana, Quim de</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2021-06-29T06:08:56Z</mods:dateAccessioned>
</mods:extension>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2021-06-29T06:08:56Z</mods:dateAvailable>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2021-06-28</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="uri">http://hdl.handle.net/10256/19663</mods:identifier>
<mods:identifier type="doi">https://doi.org/10.3390/mi12070764</mods:identifier>
<mods:identifier type="idgrec">035460</mods:identifier>
<mods:identifier type="eissn">2072-666X</mods:identifier>
<mods:abstract>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</mods:abstract>
<mods:language>
<mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">Attribution 4.0 International</mods:accessCondition>
<mods:subject>
<mods:topic>Three-dimensional printing</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Impressió 3D</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Materials biomèdics</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Biomedical materials</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Cancer Cell Direct Bioprinting: A Focused Review</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods>
</xmlData>
</mdWrap>
</dmdSec>
<amdSec ID="TMD_10256_19663">
<rightsMD ID="RIG_10256_19663">
<mdWrap MDTYPE="OTHER" MIMETYPE="text/plain" OTHERMDTYPE="DSpaceDepositLicense">
<binData>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</binData>
</mdWrap>
</rightsMD>
</amdSec>
<amdSec ID="FO_10256_19663_1">
<techMD ID="TECH_O_10256_19663_1">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>https://dugi-doc.udg.edu/bitstream/10256/19663/1/CancerCellDirect.pdf</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>3613abadef03e623c2fc50320dafb8d8</premis:messageDigest>
</premis:fixity>
<premis:size>513353</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>application/pdf</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>CancerCellDirect.pdf</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<fileSec>
<fileGrp USE="ORIGINAL">
<file ADMID="FO_10256_19663_1" CHECKSUM="3613abadef03e623c2fc50320dafb8d8" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10256_19663_1" ID="BITSTREAM_ORIGINAL_10256_19663_1" MIMETYPE="application/pdf" SEQ="1" SIZE="513353">
</file>
</fileGrp>
</fileSec>
<structMap LABEL="DSpace Object" TYPE="LOGICAL">
<div ADMID="DMD_10256_19663" TYPE="DSpace Object Contents">
<div TYPE="DSpace BITSTREAM">
</div>
</div>
</structMap>
</mets>
<?xml version="1.0" encoding="UTF-8" ?>
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Angelats Lobo, David</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Ginestra, Paola</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Ceretti, Elisabetta</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Puig i Miquel, Teresa</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Ciurana, Quim de</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2021-06-29T06:08:56Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2021-06-29T06:08:56Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2021-06-28</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="uri">http://hdl.handle.net/10256/19663</mods:identifier>
<mods:identifier type="doi">https://doi.org/10.3390/mi12070764</mods:identifier>
<mods:identifier type="idgrec">035460</mods:identifier>
<mods:identifier type="eissn">2072-666X</mods:identifier>
<mods:abstract>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Attribution 4.0 International</mods:accessCondition>
<mods:subject>
<mods:topic>Three-dimensional printing</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Impressió 3D</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Materials biomèdics</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Biomedical materials</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Cancer Cell Direct Bioprinting: A Focused Review</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods>
<?xml version="1.0" encoding="UTF-8" ?>
<datacite:resource schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4-2/metadata.xsd">
<datacite:identifier identifierType="Handle">http://hdl.handle.net/10256/19663</datacite:identifier>
<datacite:titles>
<datacite:title>Cancer Cell Direct Bioprinting: A Focused Review</datacite:title>
</datacite:titles>
<datacite:creators>
<datacite:creator>
<datacite:creatorName>Angelats Lobo, David</datacite:creatorName>
</datacite:creator>
<datacite:creator>
<datacite:creatorName>Ginestra, Paola</datacite:creatorName>
</datacite:creator>
<datacite:creator>
<datacite:creatorName>Ceretti, Elisabetta</datacite:creatorName>
</datacite:creator>
<datacite:creator>
<datacite:creatorName>Puig i Miquel, Teresa</datacite:creatorName>
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0003-2715-7043</datacite:nameIdentifier>
</datacite:creator>
<datacite:creator>
<datacite:creatorName>Ciurana, Quim de</datacite:creatorName>
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0002-6574-5551</datacite:nameIdentifier>
</datacite:creator>
</datacite:creators>
<datacite:subjects>
<datacite:subject>Three-dimensional printing</datacite:subject>
<datacite:subject>Impressió 3D</datacite:subject>
<datacite:subject>Materials biomèdics</datacite:subject>
<datacite:subject>Biomedical materials</datacite:subject>
</datacite:subjects>
<datacite:descriptions>
<datacite:description descriptionType="Abstract">Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</datacite:description>
</datacite:descriptions>
<datacite:dates>
<datacite:date dateType="Issued">2021-06-28</datacite:date>
</datacite:dates>
<datacite:publicationYear>2021</datacite:publicationYear>
<datacite:languages>
<datacite:language>eng</datacite:language>
</datacite:languages>
<datacite:relatedIdentifiers>
<datacite:relatedIdentifier relatedIdentifierType="DOI" relationType="IsSupplementTo">https://doi.org/10.3390/mi12070764</datacite:relatedIdentifier>
<datacite:relatedIdentifier relatedIdentifierType="URL" relationType="IsSupplementTo">035460</datacite:relatedIdentifier>
<datacite:relatedIdentifier relatedIdentifierType="URL" relationType="IsSupplementTo">2072-666X</datacite:relatedIdentifier>
</datacite:relatedIdentifiers>
<datacite:rightsList>
<datacite:rights>Attribution 4.0 International</datacite:rights>
<datacite:rights rightsURI="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</datacite:rights>
<datacite:rights rightsURI="info:eu-repo/semantics/openAccess">info:eu-repo/semantics/openAccess</datacite:rights>
</datacite:rightsList>
<datacite:formats>
<datacite:format>application/pdf</datacite:format>
</datacite:formats>
<datacite:publisher>MDPI (Multidisciplinary Digital Publishing Institute)</datacite:publisher>
</datacite:resource>
<?xml version="1.0" encoding="UTF-8" ?>
<atom:entry schemaLocation="http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml">
<atom:id>http://hdl.handle.net/10256/19663/ore.xml</atom:id>
<atom:published>2021-06-29T06:08:56Z</atom:published>
<atom:updated>2021-06-29T06:08:56Z</atom:updated>
<atom:source>
<atom:generator>DUGiDocs</atom:generator>
</atom:source>
<atom:title>Cancer Cell Direct Bioprinting: A Focused Review</atom:title>
<atom:author>
<atom:name>Angelats Lobo, David</atom:name>
</atom:author>
<atom:author>
<atom:name>Ginestra, Paola</atom:name>
</atom:author>
<atom:author>
<atom:name>Ceretti, Elisabetta</atom:name>
</atom:author>
<atom:author>
<atom:name>Puig i Miquel, Teresa</atom:name>
</atom:author>
<atom:author>
<atom:name>Ciurana, Quim de</atom:name>
</atom:author>
<oreatom:triples>
<rdf:Description about="http://hdl.handle.net/10256/19663/ore.xml#atom">
<dcterms:modified>2021-06-29T06:08:56Z</dcterms:modified>
</rdf:Description>
<rdf:Description about="https://dugi-doc.udg.edu/bitstream/10256/19663/3/license.txt">
<dcterms:description>LICENSE</dcterms:description>
</rdf:Description>
<rdf:Description about="https://dugi-doc.udg.edu/bitstream/10256/19663/2/license_rdf">
<dcterms:description>CC-LICENSE</dcterms:description>
</rdf:Description>
<rdf:Description about="https://dugi-doc.udg.edu/bitstream/10256/19663/1/CancerCellDirect.pdf">
<dcterms:description>ORIGINAL</dcterms:description>
</rdf:Description>
</oreatom:triples>
</atom:entry>
<?xml version="1.0" encoding="UTF-8" ?>
<qdc:qualifieddc schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
<dc:title>Cancer Cell Direct Bioprinting: A Focused Review</dc:title>
<dc:creator>Angelats Lobo, David</dc:creator>
<dc:creator>Ginestra, Paola</dc:creator>
<dc:creator>Ceretti, Elisabetta</dc:creator>
<dc:creator>Puig i Miquel, Teresa</dc:creator>
<dc:creator>Ciurana, Quim de</dc:creator>
<dc:subject>Three-dimensional printing</dc:subject>
<dc:subject>Impressió 3D</dc:subject>
<dc:subject>Materials biomèdics</dc:subject>
<dc:subject>Biomedical materials</dc:subject>
<dcterms:abstract>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</dcterms:abstract>
<dcterms:dateAccepted>2021-06-29T06:08:56Z</dcterms:dateAccepted>
<dcterms:available>2021-06-29T06:08:56Z</dcterms:available>
<dcterms:created>2021-06-29T06:08:56Z</dcterms:created>
<dcterms:issued>2021-06-28</dcterms:issued>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>http://hdl.handle.net/10256/19663</dc:identifier>
<dc:identifier>https://doi.org/10.3390/mi12070764</dc:identifier>
<dc:identifier>035460</dc:identifier>
<dc:identifier>2072-666X</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Reproducció digital del document publicat a: https://doi.org/10.3390/mi12070764</dc:relation>
<dc:relation>Micromachines, 2021, vol. 12, núm. 7, p. 764</dc:relation>
<dc:relation>Articles publicats (D-CM)</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Attribution 4.0 International</dc:rights>
<dc:publisher>MDPI (Multidisciplinary Digital Publishing Institute)</dc:publisher>
</qdc:qualifieddc>
<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication about="oai:dugi-doc.udg.edu:10256/19663">
<dc:title>Cancer Cell Direct Bioprinting: A Focused Review</dc:title>
<dc:creator>Angelats Lobo, David</dc:creator>
<dc:creator>Ginestra, Paola</dc:creator>
<dc:creator>Ceretti, Elisabetta</dc:creator>
<dc:creator>Puig i Miquel, Teresa</dc:creator>
<dc:creator>Ciurana, Quim de</dc:creator>
<dc:subject>Three-dimensional printing</dc:subject>
<dc:subject>Impressió 3D</dc:subject>
<dc:subject>Materials biomèdics</dc:subject>
<dc:subject>Biomedical materials</dc:subject>
<dc:description>Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</dc:description>
<dc:date>2021-06-29T06:08:56Z</dc:date>
<dc:date>2021-06-29T06:08:56Z</dc:date>
<dc:date>2021-06-28</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>http://hdl.handle.net/10256/19663</dc:identifier>
<dc:identifier>https://doi.org/10.3390/mi12070764</dc:identifier>
<dc:identifier>035460</dc:identifier>
<dc:identifier>2072-666X</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Reproducció digital del document publicat a: https://doi.org/10.3390/mi12070764</dc:relation>
<dc:relation>Micromachines, 2021, vol. 12, núm. 7, p. 764</dc:relation>
<dc:relation>Articles publicats (D-CM)</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Attribution 4.0 International</dc:rights>
<dc:publisher>MDPI (Multidisciplinary Digital Publishing Institute)</dc:publisher>
</ow:Publication>
</rdf:RDF>
<?xml version="1.0" encoding="UTF-8" ?>
<metadata schemaLocation="http://www.lyncode.com/xoai http://www.lyncode.com/xsd/xoai.xsd">
<element name="dc">
<element name="contributor">
<element name="author">
<element name="none">
<field name="value">Angelats Lobo, David</field>
<field name="value">Ginestra, Paola</field>
<field name="value">Ceretti, Elisabetta</field>
<field name="value">Puig i Miquel, Teresa</field>
<field name="value">Ciurana, Quim de</field>
</element>
</element>
</element>
<element name="date">
<element name="accessioned">
<element name="none">
<field name="value">2021-06-29T06:08:56Z</field>
</element>
</element>
<element name="available">
<element name="none">
<field name="value">2021-06-29T06:08:56Z</field>
</element>
</element>
<element name="issued">
<element name="none">
<field name="value">2021-06-28</field>
</element>
</element>
</element>
<element name="identifier">
<element name="uri">
<element name="none">
<field name="value">http://hdl.handle.net/10256/19663</field>
</element>
</element>
<element name="doi">
<element name="none">
<field name="value">https://doi.org/10.3390/mi12070764</field>
</element>
</element>
<element name="idgrec">
<element name="none">
<field name="value">035460</field>
</element>
</element>
<element name="eissn">
<element name="none">
<field name="value">2072-666X</field>
</element>
</element>
</element>
<element name="description">
<element name="abstract">
<element name="none">
<field name="value">Three-dimensional printing technologies allow for the fabrication of complex parts with accurate geometry and less production time. When applied to biomedical applications, two different approaches, known as direct or indirect bioprinting, may be performed. The classical way is to print a support structure, the scaffold, and then culture the cells. Due to the low efficiency of this method, direct bioprinting has been proposed, with or without the use of scaffolds. Scaffolds are the most common technology to culture cells, but bioassembly of cells may be an interesting methodology to mimic the native microenvironment, the extracellular matrix, where the cells interact between themselves. The purpose of this review is to give an updated report about the materials, the bioprinting technologies, and the cells used in cancer research for breast, brain, lung, liver, reproductive, gastric, skin, and bladder associated cancers, to help the development of possible treatments to lower the mortality rates, increasing the effectiveness of guided therapies. This work introduces direct bioprinting to be considered as a key factor above the main tissue engineering technologie</field>
</element>
</element>
<element name="provenance">
<element name="none">
<field name="value">Submitted by CLAUDIA PLANA (claudia.plana@udg.edu) on 2021-06-29T06:08:56Z No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) CancerCellDirect.pdf: 513353 bytes, checksum: 3613abadef03e623c2fc50320dafb8d8 (MD5)</field>
<field name="value">Made available in DSpace on 2021-06-29T06:08:56Z (GMT). No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) CancerCellDirect.pdf: 513353 bytes, checksum: 3613abadef03e623c2fc50320dafb8d8 (MD5) Previous issue date: 2021-06-28</field>
</element>
</element>
</element>
<element name="format">
<element name="mimetype">
<element name="none">
<field name="value">application/pdf</field>
</element>
</element>
</element>
<element name="language">
<element name="iso">
<element name="none">
<field name="value">eng</field>
</element>
</element>
</element>
<element name="publisher">
<element name="none">
<field name="value">MDPI (Multidisciplinary Digital Publishing Institute)</field>
</element>
</element>
<element name="relation">
<element name="isformatof">
<element name="none">
<field name="value">Reproducció digital del document publicat a: https://doi.org/10.3390/mi12070764</field>
</element>
</element>
<element name="ispartof">
<element name="none">
<field name="value">Micromachines, 2021, vol. 12, núm. 7, p. 764</field>
</element>
</element>
<element name="ispartofseries">
<element name="none">
<field name="value">Articles publicats (D-CM)</field>
</element>
</element>
</element>
<element name="rights">
<element name="none">
<field name="value">Attribution 4.0 International</field>
</element>
<element name="uri">
<element name="none">
<field name="value">http://creativecommons.org/licenses/by/4.0/</field>
</element>
</element>
<element name="accessRights">
<element name="none">
<field name="value">info:eu-repo/semantics/openAccess</field>
</element>
</element>
</element>
<element name="subject">
<element name="none">
<field name="value">Three-dimensional printing</field>
<field name="value">Impressió 3D</field>
<field name="value">Materials biomèdics</field>
<field name="value">Biomedical materials</field>
</element>
</element>
<element name="title">
<element name="none">
<field name="value">Cancer Cell Direct Bioprinting: A Focused Review</field>
</element>
</element>
<element name="type">
<element name="none">
<field name="value">info:eu-repo/semantics/article</field>
</element>
<element name="version">
<element name="none">
<field name="value">info:eu-repo/semantics/publishedVersion</field>
</element>
</element>
<element name="peerreviewed">
<element name="none">
<field name="value">peer-reviewed</field>
</element>
</element>
</element>
</element>
<element name="adm">
<element name="sets">
<element name="hidden">
<element name="none">
<field name="value">rc1</field>
</element>
</element>
</element>
</element>
<element name="bundles">
<element name="bundle">
<field name="name">LICENSE</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">license.txt</field>
<field name="originalName">license.txt</field>
<field name="format">text/plain</field>
<field name="size">1748</field>
<field name="url">https://dugi-doc.udg.edu/bitstream/10256/19663/3/license.txt</field>
<field name="checksum">8a4605be74aa9ea9d79846c1fba20a33</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">3</field>
</element>
</element>
</element>
<element name="bundle">
<field name="name">CC-LICENSE</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">license_rdf</field>
<field name="originalName">license_rdf</field>
<field name="format">application/rdf+xml; charset=utf-8</field>
<field name="size">908</field>
<field name="url">https://dugi-doc.udg.edu/bitstream/10256/19663/2/license_rdf</field>
<field name="checksum">0175ea4a2d4caec4bbcc37e300941108</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">2</field>
</element>
</element>
</element>
<element name="bundle">
<field name="name">ORIGINAL</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">CancerCellDirect.pdf</field>
<field name="originalName">CancerCellDirect.pdf</field>
<field name="format">application/pdf</field>
<field name="size">513353</field>
<field name="url">https://dugi-doc.udg.edu/bitstream/10256/19663/1/CancerCellDirect.pdf</field>
<field name="checksum">3613abadef03e623c2fc50320dafb8d8</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">1</field>
</element>
</element>
</element>
</element>
<element name="others">
<field name="handle">10256/19663</field>
<field name="identifier">oai:dugi-doc.udg.edu:10256/19663</field>
<field name="lastModifyDate">2022-07-18 10:16:56.882</field>
</element>
<element name="repository">
<field name="name">DUGiDocs</field>
<field name="mail">oriol.olive@udg.edu</field>
</element>
<element name="license">
<field name="bin">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</field>
</element>
</metadata>